BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34475388)

  • 1. Cell reprogramming shapes the mitochondrial DNA landscape.
    Wei W; Gaffney DJ; Chinnery PF
    Nat Commun; 2021 Sep; 12(1):5241. PubMed ID: 34475388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.
    Palombo F; Peron C; Caporali L; Iannielli A; Maresca A; Di Meo I; Fiorini C; Segnali A; Sciacca FL; Rizzo A; Levi S; Suomalainen A; Prigione A; Broccoli V; Carelli V; Tiranti V
    Stem Cell Reports; 2021 Aug; 16(8):1953-1967. PubMed ID: 34329598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC culture expansion selects against putatively actionable mutations in the mitochondrial genome.
    Kosanke M; Davenport C; Szepes M; Wiehlmann L; Kohrn T; Dorda M; Gruber J; Menge K; Sievert M; Melchert A; Gruh I; Göhring G; Martin U
    Stem Cell Reports; 2021 Oct; 16(10):2488-2502. PubMed ID: 34560000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease.
    Lee Y; Kim M; Lee M; So S; Kang SS; Choi J; Kim D; Heo H; Lee SS; Park HR; Ko JJ; Song J; Kang E
    Cell Prolif; 2022 Jul; 55(7):e13274. PubMed ID: 35698260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA Dynamics in Reprogramming to Pluripotency.
    Sercel AJ; Carlson NM; Patananan AN; Teitell MA
    Trends Cell Biol; 2021 Apr; 31(4):311-323. PubMed ID: 33422359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming.
    Yokota M; Hatakeyama H; Okabe S; Ono Y; Goto Y
    Hum Mol Genet; 2015 Aug; 24(16):4698-709. PubMed ID: 26025377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
    Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
    Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.
    Kang E; Wang X; Tippner-Hedges R; Ma H; Folmes CD; Gutierrez NM; Lee Y; Van Dyken C; Ahmed R; Li Y; Koski A; Hayama T; Luo S; Harding CO; Amato P; Jensen J; Battaglia D; Lee D; Wu D; Terzic A; Wolf DP; Huang T; Mitalipov S
    Cell Stem Cell; 2016 May; 18(5):625-36. PubMed ID: 27151456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell individual full-length mtDNA sequencing by iMiGseq uncovers unexpected heteroplasmy shifts in mtDNA editing.
    Bi C; Wang L; Fan Y; Yuan B; Ramos-Mandujano G; Zhang Y; Alsolami S; Zhou X; Wang J; Shao Y; Reddy P; Zhang PY; Huang Y; Yu Y; Izpisua Belmonte JC; Li M
    Nucleic Acids Res; 2023 May; 51(8):e48. PubMed ID: 36999592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability.
    Perales-Clemente E; Cook AN; Evans JM; Roellinger S; Secreto F; Emmanuele V; Oglesbee D; Mootha VK; Hirano M; Schon EA; Terzic A; Nelson TJ
    EMBO J; 2016 Sep; 35(18):1979-90. PubMed ID: 27436875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells.
    Park J; Lee Y; Shin J; Lee HJ; Son YB; Park BW; Kim D; Rho GJ; Kang E
    BMB Rep; 2019 Dec; 52(12):689-694. PubMed ID: 31234953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
    Moreira JD; Gopal DM; Kotton DN; Fetterman JL
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential amplification of a human mitochondrial DNA deletion in vitro and in vivo.
    Russell OM; Fruh I; Rai PK; Marcellin D; Doll T; Reeve A; Germain M; Bastien J; Rygiel KA; Cerino R; Sailer AW; Lako M; Taylor RW; Mueller M; Lightowlers RN; Turnbull DM; Helliwell SB
    Sci Rep; 2018 Jan; 8(1):1799. PubMed ID: 29379065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.